- Home
- CSTL vs FMNB Comparison
CSTL vs FMNB Comparison
Compare CSTL & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- FMNB
- Stock Information
- Founded
- CSTL 2007
- FMNB 1887
- Country
- CSTL United States
- FMNB United States
- Employees
- CSTL N/A
- FMNB N/A
- Industry
- CSTL Medical Specialities
- FMNB Major Banks
- Sector
- CSTL Health Care
- FMNB Finance
- Exchange
- CSTL Nasdaq
- FMNB Nasdaq
- Market Cap
- CSTL 471.5M
- FMNB 506.7M
- IPO Year
- CSTL 2019
- FMNB N/A
- Fundamental
- Price
- CSTL $19.36
- FMNB $13.56
- Analyst Decision
- CSTL Strong Buy
- FMNB Buy
- Analyst Count
- CSTL 6
- FMNB 2
- Target Price
- CSTL $37.67
- FMNB $15.50
- AVG Volume (30 Days)
- CSTL 554.7K
- FMNB 96.0K
- Earning Date
- CSTL 08-04-2025
- FMNB 07-23-2025
- Dividend Yield
- CSTL N/A
- FMNB 5.01%
- EPS Growth
- CSTL N/A
- FMNB N/A
- EPS
- CSTL N/A
- FMNB 1.34
- Revenue
- CSTL $346,269,000.00
- FMNB $169,440,000.00
- Revenue This Year
- CSTL N/A
- FMNB $20.80
- Revenue Next Year
- CSTL $1.62
- FMNB $8.33
- P/E Ratio
- CSTL N/A
- FMNB $10.12
- Revenue Growth
- CSTL 20.40
- FMNB 0.20
- 52 Week Low
- CSTL $14.59
- FMNB $11.58
- 52 Week High
- CSTL $35.84
- FMNB $16.29
- Technical
- Relative Strength Index (RSI)
- CSTL 58.66
- FMNB 47.74
- Support Level
- CSTL $18.81
- FMNB $13.35
- Resistance Level
- CSTL $21.33
- FMNB $13.50
- Average True Range (ATR)
- CSTL 0.92
- FMNB 0.35
- MACD
- CSTL 0.45
- FMNB -0.04
- Stochastic Oscillator
- CSTL 70.74
- FMNB 35.43
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.